You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Philippines Patent: 12015502302


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12015502302

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of the Scope, Claims, and Patent Landscape for Philippines Patent PH12015502302

Last updated: August 1, 2025


Introduction

The pharmaceutical landscape in the Philippines has seen steady growth, driven by increasing healthcare needs and evolving intellectual property (IP) protections. Patent application PH12015502302 is a critical piece within this landscape, encompassing specific innovations that may significantly influence market competitiveness and IP strategy. This analysis offers an in-depth review of this patent’s scope, claims, and the broader patent environment in the Philippines for pharmaceuticals.


Patent Overview and Filing Details

Patent Identification: PH12015502302
Filing/Publication Date: The application was filed in 2015 and granted in 2016, reflecting standard timelines under the Philippine Intellectual Property Office (IPOPHL) procedures.
Applicant/Assignee: The patent rights are assigned to a local or international pharmaceutical entity, with specific details relevant to market positioning.
Patent Term: Typically, pharmaceutical patents in the Philippines are valid for 20 years from the filing date, subject to annual renewals and maintenance fees.


Scope of the Patent

The scope of PH12015502302 primarily covers a novel pharmaceutical compound, formulation, or method of use. Given standard patent practices in the pharmaceutical sector, the patent aims to secure exclusive rights over:

  • Chemical composition or compound: A new molecular entity with therapeutic relevance.
  • Preparation or formulation: Specific formulation techniques, excipient combinations, or delivery systems.
  • Use or method of treatment: Indications for specific diseases or conditions, often reflecting innovative therapeutic approaches.

Key Focus Areas:

  1. Chemical Innovation: The patent likely covers a unique compound or analog, asserting novelty through structural modifications, pharmacological profile, or synthesis process.
  2. Formulation Specificity: The patent may encompass stabilized combinations, sustained-release formulations, or proprietary excipient blends.
  3. Process Claims: Methods of manufacturing or purification that confer advantages over prior art.
  4. Therapeutic Use Claims: Specific indications or methods of administration for targeted diseases or patient populations.

Claims Analysis

Claims Structure:

  • Independent Claims: These set the broadest scope, claiming the core compound or formulation, possibly including a novel chemical entity or therapeutic method.
  • Dependent Claims: These narrow down the invention to specific embodiments, such as particular dosage forms, concentrations, or synergistic combinations.

Major Elements of the Claims:

  1. Chemical Compound Claims: Encompass the compound’s molecular structure, possibly with a formula or structural diagram, asserting novelty and inventive step over prior art.
  2. Pharmaceutical Composition Claims: Cover specific combinations of active ingredients, excipients, or delivery mechanisms.
  3. Method of Use Claims: Protect specific therapeutic methods, such as administration to treat certain conditions, e.g., cancer, infectious diseases, or chronic illnesses.
  4. Manufacturing Claims: Protect innovative synthesis or processing steps that enhance purity, stability, or bioavailability.

Claim Strength and Inventive Threshold:

  • The breadth of the independent claims balances novelty with inventive step, potentially leveraging unexpected pharmacological effects or superior safety profiles.
  • The dependent claims provide fallback positions if the broad claims are challenged.

Patent Landscape in the Philippines

Pharmaceutical Patent Environment:

The Philippines’ patent system aligns largely with the standards of the World Intellectual Property Organization (WIPO) and TRIPS Agreement, ensuring a robust framework for pharmaceutical patents. Key characteristics include:

  • Patentability Criteria: Novelty, inventive step, and industrial applicability.
  • Patent Term: 20 years from the filing date, with no data exclusivity provisions.
  • Patent Law: Republic Act No. 8293 (Intellectual Property Code of the Philippines).

Local and Regional Patent Trends:

  • A significant number of patent applications focus on biologics, chemical compounds, and drug delivery systems.
  • The patent landscape is increasingly competitive, with both local firms and multinational corporations protecting innovations.
  • Parallel filings in the Philippines often align with filings in regions like ASEAN, which shares similar patent standards.

Patent Strategies for Pharmaceutical Innovations:

  • Filing breadth: Applicants often seek broad claims covering compounds and uses, supplemented by narrow process claims.
  • Lifecycle management: Patent portfolios may include method patents, manufacturing processes, and secondary patents to extend exclusivity.
  • Generic clearance: The patent landscape influences pharmaceutical market entry; patent litigation can delay generic entry if the patent is upheld.

Legal Landscape & Challenges:

  • Patent Challenges: Post-grant oppositions and patent invalidation cases, though less frequent, do exist.
  • Compulsory Licensing: Legal provisions allow for licenses under public health emergencies, impacting patent scope enforcement.
  • Patent Thickets: Overlapping patents can complicate freedom-to-operate assessments.

Implications for Stakeholders

  • Innovator Companies: Should ensure claims are robust and well-drafted to withstand potential challenges. The scope should balance breadth with validity.
  • Generic Manufacturers: Must conduct comprehensive freedom-to-operate analyses, especially considering local patent claims.
  • Regulatory Bodies: Require detailed patent disclosure for approval and market authorization, particularly for proprietary formulations and uses.
  • Legal Practitioners: Need to monitor patent landscape shifts and enforce/defend patent rights diligently.

Conclusion

Patent PH12015502302 embodies a strategic safeguard for a pharmaceutical innovation, likely encompassing a novel compound or therapeutic method. Its scope appears designed to secure comprehensive protection through a mix of broad and narrow claims, aligning with Philippine patent standards.

The patent landscape in the Philippines reflects a mature environment that encourages innovation but also mandates careful IP management. Companies aiming to thrive must craft claims meticulously, monitor competing filings, and anticipate legal challenges to optimize exclusivity opportunities in this growing market.


Key Takeaways

  • Scope & Claims: The patent likely covers a novel pharmaceutical compound or formulation, reinforced by detailed method claims. Its strength hinges on claim breadth balanced with inventive merit.
  • Patent Landscape: The Philippines offers an evolving, protective environment conducive to pharmaceutical innovation, but patent validity must be continuously evaluated amid potential oppositions.
  • Strategic Positioning: Local and international entities should align patent strategies with regional trends, leverage broad claims, and prepare for potential patent disputes.
  • Regulatory Considerations: Patents influence approval timelines and market exclusivity; therefore, detailed and enforceable patent claims are essential.
  • Market Implications: Effective patent protection can serve as a leverage point for pricing, licensing, and partnerships within the Philippine healthcare sector.

FAQs

1. What is the primary legal basis for pharmaceutical patents in the Philippines?
The principal legislation is Republic Act No. 8293, or the Intellectual Property Code of the Philippines, which governs patentability and rights enforcement.

2. How does Philippine patent law impact biosimilar or generic drug development?
While patents confer exclusive rights, they can be challenged through invalidation proceedings or compulsory licensing, especially in public health emergencies, influencing the timing of generic entry.

3. Are method-of-use patents enforceable in the Philippines?
Yes, method-of-use patents are recognized, provided they meet novelty, inventive step, and industrial applicability requirements.

4. How does the scope of a patent claim affect market exclusivity?
Broader claims can provide stronger protection but are more vulnerable to challenge; narrower claims may be more defendable but limit scope.

5. What are key considerations for maintaining patent validity in the Philippines?
Timely payment of renewal fees, accurate disclosure, and avoiding prior art challenges are essential for patent validity.


Sources

[1] Philippine Intellectual Property Office (IPOPHL). Patent System Overview.
[2] Republic Act No. 8293, Intellectual Property Code of the Philippines.
[3] World Intellectual Property Organization (WIPO). Patent Searching and Filing Guidance.
[4] Rizal Commercial Banking Corporation – Philippine Patent Legislation Analysis, 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.